科研之友
微信
新浪微博
Facebook
分享链接
摘要
Background and Purpose 1-Methyl-4-phenylpyridinium (MPP+), a potent parkinsonizing agent in primates and rodents, is a blocker of mitochondrial complex I, therefore MPP+-induced parkinsonism is believed to depend largely on mitochondrial impairment. However, it has recently been proposed that other mechanisms may participate in MPP+-induced toxicity. We tackled this issue by probing the effects of an acute application of MPP+ on substantia nigra pars compacta (SNc) dopamine (DA) neurons. Experimental Approach The effects of MPP+ on SNc DA neurons in acute midbrain slices were investigated with electrophysiology techniques. Key Results MPP+ (50M) was able to (i) hyperpolarize SNc DA neurons by approximate to 6mV; (ii) cause an abrupt and marked (over 50%) reduction of the spontaneous activity; and (iii) inhibit the hyperpolarization-activated inward current (Ih). MPP+ shifted Ih activation curve towards negative potentials by approximate to 11mV both in Wistar rats and in C57/BL6 mice. Inhibition was voltage- and concentration-dependent (Imax = 47%, IC50 = 7.74M). MPP+ slowed Ih activation kinetics at all potentials. These effects were not dependent on (i) block of mitochondrial complex I/fall of ATP levels; (ii) activation of type 2 DA receptor; and (iii) alteration of cAMP metabolism. Finally, MPP+-dependent inhibition of Ih facilitated temporal summation of evoked EPSPs in SNc DA, but not in CA1 hippocampal neurons. Conclusion and Implications Reduced functionality of Ih in SNc DA neurons, via increased responsiveness towards synaptic excitation, might play a role in MPP+-induced parkinsonism and, possibly, in the pathogenesis of human Parkinson%26apos;s.
- 出版日期2013-5
